(2018). Retraction: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF. Cancer Res.
Chicago-tyylinen lähdeviittaus"Retraction: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells Through Modulation of MiR-200 and MiR-21 Expression By Curcumin or Its Analogue CDF." Cancer Res 2018.
MLA-viite"Retraction: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells Through Modulation of MiR-200 and MiR-21 Expression By Curcumin or Its Analogue CDF." Cancer Res 2018.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.